Teva Pharmaceutical Industries Limited (FRA:TEV)

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,161	3,300	3,226	2,801	2,165	2,177
Cash & Short-Term Investments	2,161	3,300	3,226	2,801	2,165	2,177
Cash Growth	-4.30%	2.29%	15.17%	29.38%	-0.55%	10.23%
Receivables	3,564	3,059	3,408	3,696	4,529	4,581
Inventory	3,497	3,007	4,021	3,833	3,818	4,403
Prepaid Expenses	1,084	1,006	1,255	1,162	1,075	945
Restricted Cash	-	-	1	33	33	-
Other Current Assets	2,314	2,180	574	526	953	899
Total Current Assets	12,620	12,552	12,485	12,051	12,573	13,005
Property, Plant & Equipment	5,168	4,948	6,147	6,158	6,477	6,855
Long-Term Investments	-	-	8	-	-	-
Goodwill	15,949	15,147	17,177	17,633	20,040	20,624
Other Intangible Assets	4,142	4,418	5,387	6,270	7,466	8,923
Long-Term Deferred Tax Assets	1,781	1,799	1,812	1,458	596	695
Other Long-Term Assets	471	462	463	441	514	538
Total Assets	40,131	39,326	43,479	44,011	47,666	50,640
Accounts Payable	2,498	2,203	2,602	1,887	1,686	1,756
Accrued Expenses	3,576	5,651	5,525	4,955	5,280	5,347
Current Portion of Long-Term Debt	464	1,781	1,672	2,109	1,426	3,188
Current Portion of Leases	-	87	97	93	109	116
Other Current Liabilities	5,323	3,074	2,351	2,425	2,526	2,757
Total Current Liabilities	11,861	12,796	12,247	11,469	11,027	13,164
Long-Term Debt	16,763	16,002	18,161	19,103	21,617	22,731
Long-Term Leases	296	314	343	371	441	500
Long-Term Deferred Tax Liabilities	440	483	606	548	784	964
Other Long-Term Liabilities	3,937	3,948	3,923	3,922	2,553	2,220
Total Liabilities	33,297	33,606	35,353	35,413	36,422	39,579
Common Stock	6,827	58	57	57	57	57
Additional Paid-In Capital	-	27,764	27,807	27,688	27,561	27,443
Retained Earnings	-	-15,173	-13,534	-12,975	-10,529	-10,946
Treasury Stock	-	-4,128	-4,128	-4,128	-4,128	-4,128
Comprehensive Income & Other	-	-3,148	-2,696	-2,838	-2,683	-2,400
Total Common Equity	6,827	5,373	7,506	7,804	10,278	10,026
Minority Interest	7	347	620	794	966	1,035
Shareholders' Equity	6,834	5,720	8,126	8,598	11,244	11,061
Total Liabilities & Equity	40,131	39,326	43,479	44,011	47,666	50,640
Total Debt	17,523	18,184	20,273	21,676	23,593	26,535
Net Cash (Debt)	-15,362	-14,884	-17,047	-18,875	-21,428	-24,358
Net Cash Per Share	-13.50	-13.16	-15.23	-17.00	-19.36	-22.24
Filing Date Shares Outstanding	1,147	1,134	1,121	1,111	1,103	1,097
Total Common Shares Outstanding	1,147	1,134	1,121	1,111	1,103	1,097
Working Capital	759	-244	238	582	1,546	-159
Book Value Per Share	5.95	4.74	6.70	7.02	9.32	9.14
Tangible Book Value	-13,264	-14,192	-15,058	-16,099	-17,228	-19,521
Tangible Book Value Per Share	-11.56	-12.52	-13.43	-14.49	-15.61	-17.80
Land	-	213	246	246	262	292
Buildings	-	1,968	2,488	2,463	2,568	2,720
Machinery	-	5,480	7,226	7,349	7,359	7,443
Construction In Progress	-	1,330	1,427	1,199	1,034	933

Source: S&P Global Market Intelligence. Standard template. Financial Sources.